These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6291686

  • 1. The effects of monovalent and divalent cations on the alpha-adrenoceptor of intact human platelets.
    Elliott JM, Grahame-Smith DG.
    Br J Pharmacol; 1982 Oct; 77(2):277-83. PubMed ID: 6291686
    [Abstract] [Full Text] [Related]

  • 2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F, Cazenave JP.
    Thromb Haemost; 1985 Aug 30; 54(2):402-8. PubMed ID: 3001964
    [Abstract] [Full Text] [Related]

  • 3. The binding characteristics of [3H]-dihydroergocryptine on intact human platelets.
    Elliott JM, Grahame-Smith DG.
    Br J Pharmacol; 1982 May 30; 76(1):121-30. PubMed ID: 6805543
    [Abstract] [Full Text] [Related]

  • 4. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.
    Boon NA, Elliott JM, Grahame-Smith DG, St John-Green T, Stump K.
    J Auton Pharmacol; 1983 Jun 30; 3(2):89-95. PubMed ID: 6309852
    [Abstract] [Full Text] [Related]

  • 5. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
    Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ.
    J Clin Invest; 1978 Feb 30; 61(2):395-402. PubMed ID: 23392
    [Abstract] [Full Text] [Related]

  • 6. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ, Insel PA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2591-7. PubMed ID: 6291538
    [Abstract] [Full Text] [Related]

  • 7. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES, Addonizio VP, Shattil SJ.
    Am J Physiol; 1982 Jan 15; 242(1):H19-23. PubMed ID: 6277203
    [Abstract] [Full Text] [Related]

  • 8. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.
    Garcia-Sevilla JA, Fuster MJ.
    Eur J Pharmacol; 1986 May 13; 124(1-2):31-41. PubMed ID: 3013661
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides.
    Michel T, Hoffman BB, Lefkowitz RJ.
    Nature; 1980 Dec 25; 288(5792):709-11. PubMed ID: 6256638
    [Abstract] [Full Text] [Related]

  • 10. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D.
    J Clin Invest; 1984 Sep 25; 74(3):1063-72. PubMed ID: 6088579
    [Abstract] [Full Text] [Related]

  • 11. [3H]-guanfacine: a radioligand that selectively labels high affinity alpha2-adrenoceptor sites in homogenates of rat brain.
    Jarrott B, Louis WJ, Summers RJ.
    Br J Pharmacol; 1982 Feb 25; 75(2):401-8. PubMed ID: 6138110
    [Abstract] [Full Text] [Related]

  • 12. Sodium modulation of 3H-agonist and 3H-antagonist binding to alpha 2-adrenoceptor subtypes.
    MacKinnon AC, Spedding M, Brown CM.
    Br J Pharmacol; 1993 Jun 25; 109(2):371-8. PubMed ID: 8102928
    [Abstract] [Full Text] [Related]

  • 13. Agonist versus antagonist binding to alpha-adrenergic receptors.
    Hoffman BB, Michel T, Kilpatrick DM, Lefkowitz RJ, Tolbert ME, Gilman H, Fain JN.
    Proc Natl Acad Sci U S A; 1980 Aug 25; 77(8):4569-73. PubMed ID: 6107908
    [Abstract] [Full Text] [Related]

  • 14. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT, Lefkowitz RJ.
    Mol Pharmacol; 1977 Mar 25; 13(2):304-13. PubMed ID: 192992
    [No Abstract] [Full Text] [Related]

  • 15. Differential labeling of platelet alpha 2 adrenoceptors by 3H dihydroergocryptine and 3H yohimbine in patients with myeloproliferative disorders.
    Swart SS, Wood JK, Barnett DB.
    Thromb Res; 1985 Dec 01; 40(5):623-9. PubMed ID: 3003960
    [Abstract] [Full Text] [Related]

  • 16. Human myometrial adrenergic receptors during pregnancy: identification of the alpha-adrenergic receptor by [3H] dihydroergocryptine binding.
    Jacobs MM, Hayashida D, Roberts JM.
    Am J Obstet Gynecol; 1985 Jul 15; 152(6 Pt 1):680-4. PubMed ID: 2992273
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW, Cooper B, Handin RI.
    J Clin Invest; 1978 May 15; 61(5):1136-44. PubMed ID: 207726
    [Abstract] [Full Text] [Related]

  • 18. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V, McNeill JR, Sulakhe PV, Triggle CR.
    Endocrinology; 1988 Aug 15; 123(2):922-31. PubMed ID: 2969327
    [Abstract] [Full Text] [Related]

  • 19. Platelet functions, alpha 2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert.
    Lanza F, Cazenave JP, Hemmendinger S, Stierlé A, Tranchant C, Warter JM.
    J Neurol Sci; 1987 Jun 15; 79(1-2):13-22. PubMed ID: 3039064
    [Abstract] [Full Text] [Related]

  • 20. Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding.
    Motulsky HJ, Insel PA.
    J Biol Chem; 1983 Mar 25; 258(6):3913-9. PubMed ID: 6300062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.